(Q73599937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

phase I clinical trial

1 reference

John P Leonard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Morton Coleman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jamie C Ketas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Amy Chadburn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Scott Ely

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Richard R Furman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

William A Wegener

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hans J Hansen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Heather Ziccardi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Michael Eschenberg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Urte Gayko

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Alessandra Cesano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

David M Goldenberg

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

3051-3059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Identifiers

DOI

10.1200/JCO.2003.01.082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12837807%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference